Will you be at the World Orphan Drug Congress? Let’s meet!

You need delivery on-time: The combined leadership expertise, unique geographic placement and highly experienced operational team at Worldwide Clinical Trials means that we can deliver your studies on-time, every time! 

You want a team attuned to your unique challenges: Worldwide provides unrivaled therapeutic expertise and operational excellence across all phases of development in neuroscience, cardiovascular disease, inflammatory disorders, and rare disease.

You’re in luck! Our team will be available during the World Orphan Drug Congress to discuss a plan that can help maximize the success of your projects.

Visit us at Booth #311 or schedule a meeting today!

Overcoming Operational Challenges in Rare Disease Trials
Participate in Our Roundtable Discussion

Leslie Wetherell
Executive Director, Global Project Management, Rare Disease Franchise Lead

Leslie has over 20 years in the pharmaceutical industry, working in biotech, pharmaceutical, and the CRO industry. She is responsible for the portfolio of rare disease and oncology studies within the immune mediated inflammatory disorder therapeutic area. She began her career in data management and moved into project management for a small CRO focused on biotech. She then moved to an oversight role at a large CRO where she worked as an oversight director for many large phase III programs, as well as development of oncology and rare disease molecules in all phases. She was the operational director for the rare disease-working group at a large CRO where she was responsible for global strategy, implementation, and risk mitigation for rare disease projects across therapeutic areas. Throughout her career, she has worked on over 30 studies and 5 NDA submissions and has operational experience in over 40 countries.

Seats for this panel are limited!
Express your interest by completing the form on the right.
On-Demand Webinar

Worldwide experts come together to address rare disease clinical trials and the opportunity for innovative trial design and executions. Topics include:

  • Emerging opportunities for an “outside the box” approach to study and program design
  • The importance of appreciating the illness, not just understanding the disease
  • Family engagement informing both trial design as well as operational strategy
  • Translating innovative designs into predictable high quality execution

Whether it’s your first time or you’re returning to the World Orphan Drug Congress, we know that you want to make the most of your visit to Washington, DC. We developed this ‘Top 5 Spots to Visit’ guide to help you uncover the most memorable places to see during your stay in this amazing city.

About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization, helping bring innovative solutions to market that deliver enhanced value and improve patient lives. Our employees are among the best in their fields – clinicians, scientists, operational and regulatory specialists who offer expertise across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit our website.

Schedule a Meeting: